TransDigm Group Incorporated (NYSE:TDG – Free Report) – Equities researchers at William Blair lifted their Q4 2024 earnings estimates for TransDigm Group in a research report issued on Wednesday, June 26th. William Blair analyst L. Dipalma now expects that the aerospace company will post earnings of $8.29 per share for the quarter, up from their prior estimate of $8.03. The consensus estimate for TransDigm Group’s current full-year earnings is $30.04 per share. William Blair also issued estimates for TransDigm Group’s FY2025 earnings at $36.29 EPS.
Several other research firms also recently issued reports on TDG. Wells Fargo & Company increased their price objective on shares of TransDigm Group from $1,260.00 to $1,390.00 and gave the company an “equal weight” rating in a report on Wednesday, May 8th. Stifel Nicolaus lifted their price objective on TransDigm Group from $1,300.00 to $1,325.00 and gave the stock a “hold” rating in a report on Friday, June 7th. Susquehanna increased their target price on TransDigm Group from $1,100.00 to $1,200.00 and gave the company a “neutral” rating in a report on Wednesday, May 8th. TD Cowen lifted their price target on TransDigm Group from $1,300.00 to $1,400.00 and gave the stock a “buy” rating in a research note on Wednesday, May 8th. Finally, Morgan Stanley increased their price objective on TransDigm Group from $1,275.00 to $1,550.00 and gave the company an “overweight” rating in a research note on Thursday, May 9th. Six investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $1,414.06.
TransDigm Group Price Performance
Shares of NYSE:TDG opened at $1,278.10 on Monday. The business’s 50 day moving average price is $1,304.81 and its 200-day moving average price is $1,188.76. TransDigm Group has a 1 year low of $802.46 and a 1 year high of $1,369.57. The firm has a market capitalization of $71.52 billion, a price-to-earnings ratio of 50.70, a price-to-earnings-growth ratio of 2.16 and a beta of 1.38.
TransDigm Group (NYSE:TDG – Get Free Report) last released its quarterly earnings results on Tuesday, May 7th. The aerospace company reported $7.99 earnings per share for the quarter, topping analysts’ consensus estimates of $7.42 by $0.57. TransDigm Group had a negative return on equity of 63.35% and a net margin of 21.22%. The company had revenue of $1.92 billion during the quarter, compared to analysts’ expectations of $1.88 billion. During the same quarter in the prior year, the firm posted $5.39 EPS. TransDigm Group’s quarterly revenue was up 20.5% compared to the same quarter last year.
Insider Activity at TransDigm Group
In other TransDigm Group news, CEO Kevin M. Stein sold 10,000 shares of the stock in a transaction that occurred on Friday, April 12th. The shares were sold at an average price of $1,216.16, for a total value of $12,161,600.00. Following the sale, the chief executive officer now directly owns 8,158 shares of the company’s stock, valued at approximately $9,921,433.28. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. In other news, COO Joel Reiss sold 3,000 shares of TransDigm Group stock in a transaction dated Monday, April 15th. The stock was sold at an average price of $1,233.10, for a total transaction of $3,699,300.00. Following the sale, the chief operating officer now owns 3,600 shares in the company, valued at $4,439,160. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Kevin M. Stein sold 10,000 shares of the company’s stock in a transaction dated Friday, April 12th. The shares were sold at an average price of $1,216.16, for a total value of $12,161,600.00. Following the completion of the sale, the chief executive officer now directly owns 8,158 shares of the company’s stock, valued at $9,921,433.28. The disclosure for this sale can be found here. Insiders have sold a total of 100,833 shares of company stock valued at $131,249,183 over the last 90 days. 4.96% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On TransDigm Group
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Compagnie Lombard Odier SCmA acquired a new position in shares of TransDigm Group in the 4th quarter valued at $25,000. Oakworth Capital Inc. acquired a new stake in shares of TransDigm Group during the fourth quarter worth about $26,000. ORG Partners LLC purchased a new position in shares of TransDigm Group during the first quarter worth about $30,000. VisionPoint Advisory Group LLC acquired a new position in TransDigm Group in the 4th quarter valued at about $37,000. Finally, Oliver Lagore Vanvalin Investment Group raised its stake in TransDigm Group by 48.0% during the 4th quarter. Oliver Lagore Vanvalin Investment Group now owns 37 shares of the aerospace company’s stock valued at $38,000 after acquiring an additional 12 shares during the last quarter. Hedge funds and other institutional investors own 95.78% of the company’s stock.
About TransDigm Group
TransDigm Group Incorporated designs, produces, and supplies aircraft components in the United States and internationally. The Power & Control segment offers mechanical/electro-mechanical actuators and controls, ignition systems and engine technology, specialized pumps and valves, power conditioning devices, specialized AC/DC electric motors and generators, batteries and chargers, databus and power controls, sensor products, switches and relay panels, hoists, winches and lifting devices, and cargo loading and handling systems.
Featured Articles
- Five stocks we like better than TransDigm Group
- How to Calculate Options Profits
- RXO Shares Surge Following New Acquisition Deal
- Overbought Stocks Explained: Should You Trade Them?
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- What Are Dividend Contenders? Investing in Dividend Contenders
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for TransDigm Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TransDigm Group and related companies with MarketBeat.com's FREE daily email newsletter.